Journals / MN Kardiyoloji / 2003 / Cilt: 10 - Sayı: 2

A case of premature myocardial infarction due to chemotherapeutic agents

Kemoterapötik ajanlara bağlı genç miyokard infraktüsü olgusu

Pages
134–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The physiopathological mechanisms of causal relationship between the chemotherapy regimen and myocardial ischemia are discussed and the importance of the awareness of such a complication is emphasized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 36-year-old man with non-Hodgkin's lymphoma disease was presented with acute myocardial infarction during the fifth cycle of chemotherapy with cytarabine, etoposide and cisplatin.
📊
Key Findings & Data:He had no significant risk factors for coronary heart disease and coronary angiogram revealed normal coronaries meanwhile ventriculography showed an apical akinesia.
💡
Conclusion & Impact:The physiopathological mechanisms of causal relationship between the chemotherapy regimen and myocardial ischemia are discussed and the importance of the awareness of such a complication is emphasized.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antineoplastik ajanlar · Miyokard enfarktüsü · Miyokard iskemisi

Abstract

A 36-year-old man with non-Hodgkin's lymphoma disease was presented with acute myocardial infarction during the fifth cycle of chemotherapy with cytarabine, etoposide and cisplatin. He had no significant risk factors for coronary heart disease and coronary angiogram revealed normal coronaries meanwhile ventriculography showed an apical akinesia. The physiopathological mechanisms of causal relationship between the chemotherapy regimen and myocardial ischemia are discussed and the importance of the awareness of such a complication is emphasized.

Özet

Bu yazıda 36 yaşında "non-Hodgkin" lenfoma tanısı ile beşinci kür kemoterapisini (sitarabin, etoposide ve cisplatin) alırken akut miyokard infarktüsü gelişen bir olgu sunulmuştur. Koroner arter hastalığı risk faktörü taşımayan, koronerleri anjiyografide normal bulunan ve apikal diskinezi saptanan bu premature miyokard infarktüsü olgusu dolayısı ile kemoterapi rejimi ile miyokardiyal iskemi arasındaki patofizolojik ilişki tartışılarak genç hastalarda da böyle bir komplikasyona karşı bilgili olmanın önemi vurgulanmıştır.

🔖

Cite This Article

KIRILMAZ, B., KAYIKÇIOĞLU, M., ALİYEV, E., PAYZIN, S., TÜRKOĞLU, C. (2003). A case of premature myocardial infarction due to chemotherapeutic agents. MN Kardiyoloji, Cilt: 10 - Sayı: 2, 134–137. https://ajindex.com/articles/297700

References (14)

  1. Braunwald E, Zipes DP, Libby P. Heart disease: a textbok of cardiovasculer medicine 6th edition. 2001:2223-4.
  2. Brestescher C, Patuier P, Farge D. Chemotherapy and cardi otoxicity. Ann Cardiol Angiol 1995; 44:443-7.
  3. Caron F, Valy Y, Meurice JC, Preault MC, Patte F. Myocar dial infarction during a treatment combining etoposide and cisp latin. Presse Med 1997; 26:1674. Sasaki M, Suzuki A, Ishiara T. A case of acute myocardial in farction after treatment with cisplatin. Gan To Kagaku Ryoho 1989; 16:2289-91.
  4. Schwarzer S, Eber B, Greinix H, Lind P Non-Q-wave myo cardial infarction associated with bleomycin and etoposide che motherapy. Eur Heart J 1991; 12:748-50.
  5. Tsutsumi T, Ozawa Y, Kawakami A, Fujii H, Asamato H. Acute myocardial infarction induced by lung cancer chemo-the rapy with cisplatin and etoposide. Gan To Kagaku Ryoho 1990; 17:413-7.
  6. Mermershtain W, Dudnik J, Gusakova T, Ariad S. Acute myocardial infarction in a young man receiving chemotherapy for testiculer cancer: case report. J Chemother 2001; 13:658-60.
  7. Dachmeyer C, Joly H, Jorest R. Early myocardial infarction du ring chemotherapy for testiculer cancer. Tumori 2000; 86:428-30. Gerl A. Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs 1994; 5:607-14.
  8. Iclı F, Karaoguz H, Dmcol D, Demirkazık A, Gunel N, Karaoguz R, Uner A. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993; 72:587-93.
  9. Samuels BL, Vogelzang NJ, Kennedy BJ. Severe vasculer toxicity associated with vinblastine, bleomycin and cisplatin chemotherapy. Cancer Chemother Pharmacol 1987; 19:253-6.
  10. Borek G, Gebel F, Jenzer HR. Schweiz. Acute myocardial infarct following chemotherapy for testiculer carsinoma:on the coronary toxicity of cytostatic agents. Med Woschenschr 1991; 16:385-9.
  11. Schecter JP, Jones SE, Jackson RA. Myocardial infarction in a 27-year-old woman:possible complication of treatment with VP-16-213. Cancer Chemother Rep 1975; 59:887-8.
  12. Aırey CL, Dodwell DJ, Joffe JK, Jones WK. Etoposide rela­ted myocardial infarction Clin Oncol (R Coll Radiol) 1995; 7:135-1.
  13. Edwards RL, Silver J, Rickles FR. Human tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malig­nancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis. Thromb. Haemost. 1993; 69:205-13.
  14. Gordon SG, Mielicki WP. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Blood Coagul Fibrinol 1997; 8:73-